Craneware (CRW)

Sector:

Health Care

Index:

FTSE AIM 100

1,355.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 2,640.00p
  • 52 Week Low: 1,340.00p
  • Currency: UK Pounds
  • Shares Issued: 35.54m
  • Volume: 254,973
  • Market Cap: £481.60m
  • RiskGrade: 185

Craneware performs well as it completes Sentry acquisition

By Josh White

Date: Tuesday 21 Sep 2021

LONDON (ShareCast) - (Sharecast News) - United States healthcare software company Craneware reported a 6% improvement in revenue in its final results on Tuesday, to $75.6m.
The AIM-traded firm said its three-year total visible revenue for the year ended 30 June, including the contribution from Sentry from 13 July onwards, was $471.2m, up from $196.2m at the same time last year.

Adjusted EBITDA was 8% firmer year-on-year at $27.1m, while profit before tax fell to $13.2m from $19.3m, which the board said reflected exceptional costs associated with the funding of acquisitions.

Basic adjusted earnings per share increased 6% to 69 cents, and adjusted diluted earnings per share increased to 68.1 cents from 64.4 cents.

The company said basic earnings per share came in at 48.1 cents, down from 62.8 cents, and diluted earnings per share were 47.5 cents, falling from 61.9 cents.

Operating cash conversion was described as "strong", at 99% of adjusted EBITDA, rising from 92% in the 2020 financial year.

Cash at year-end totalled $235.6m, up from $47.9m a year earlier, after the company raised $187.3m net via a share placing, and prior to the completion of the Sentry acquisition.

The board proposed an increase in the final dividend to 15.5p, or 21.47 cents, per share, up from 15p and 18.45 cents for 2020, respectively.

That would make for a total dividend for the year of 27.5p, or 38.1 cents, per share, rising from 26.5p and 32.60 cents a year ago.

Looking ahead, the company said it was seeing continued sales momentum across the now-enlarged group, with the integration of Sentry proceeding faster than its initial expectations.

It said the long-term transition to "value-based care" in the sector provided an ongoing basis for growth, with the board saying it was "confident" in a return to double-digit organic growth in future years.

"Our team delivered a positive performance in the year, against the ongoing backdrop of the pandemic, supporting our customers through an incredibly challenging period while continuing to execute on our strategy," said chief executive officer Keith Neilson.

"We experienced continued sales momentum and strong adoption of our Trisus cloud based platform, paving the way for accelerated future growth.

"The successful completion of the acquisition of Sentry Data Systems following the end of the year marks a transformational point in our journey, considerably expanding our customer base, data sets, product offering and market presence."

Neilson said the combined companies would offer healthcare organisations "innovative" ways to measurably improve operational and financial performance, to generate sustainable margins.

"With a strong balance sheet, high levels of recurring revenues, high customer retention rates and visible revenue in the next three years of $471.2m, we have a strong financial foundation from which to accelerate growth and to fulfil our potential, thereby increasing future shareholder value.

"We have enjoyed early sales momentum across the now-enlarged group, and with our expanded opportunity we look to the future with considerable excitement and confidence as we work with the Sentry team to transform the business of US healthcare."

At 1011 BST, shares in Craneware were up 0.87% at 2,320p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Craneware Market Data

Currency UK Pounds
Share Price 1,355.00p
Change Today -10.00p
% Change -0.73 %
52 Week High 2,640.00p
52 Week Low 1,340.00p
Volume 254,973
Shares Issued 35.54m
Market Cap £481.60m
RiskGrade 185

Craneware Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.93% below the market average88.93% below the market average88.93% below the market average88.93% below the market average88.93% below the market average
12.82% below the sector average12.82% below the sector average12.82% below the sector average12.82% below the sector average12.82% below the sector average
Price Trend
83.42% below the market average83.42% below the market average83.42% below the market average83.42% below the market average83.42% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Income
50.59% below the market average50.59% below the market average50.59% below the market average50.59% below the market average50.59% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Growth
55.61% below the market average55.61% below the market average55.61% below the market average55.61% below the market average55.61% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Craneware Dividends

  Latest Previous
  Interim Final
Ex-Div 24-Mar-22 25-Nov-21
Paid 14-Apr-22 21-Dec-21
Amount 12.50p 15.50p

Trades for 26-May-2022

Time Volume / Share Price
16:35 912 @ 1,355.00p
16:01 1,911 @ 1,351.00p
16:01 29 @ 1,351.03p
15:41 263 @ 1,357.00p
15:38 295 @ 1,360.00p

Craneware Key Personnel

CEO Keith Neilson

Top of Page